Alimera Sciences Inc Extends Gains On FDA News
September 29, 2014 at 10:59 AM EDT
Alimera Sciences Inc (NASDAQ: ALIM) extended its gains Monday after the company's treatment for diabetes-related vision loss won ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.